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Edited by Felix WielandAbstract The nuclear internalization of biomolecules by Tat
peptide provides a mechanism to deliver drugs to cells. However,
translocation of molecular imaging probes to the nucleus may in-
duce undesirable mutagenesis. To assess the feasibility of retain-
ing its cell permeating eﬀect without nuclear translocation, Tat-
peptide was conjugated with a somatostatin receptor (STR)-avid
ligand (Oct) and labeled with ﬂuorescent dyes. The results show
that Tat-Oct-5-FAM (ﬂuorescein 5 0-carboxylic acid) remained
in the cytoplasm of STR-positive AR42J cells. Co-incubation
of Tat-Oct-5-FAM with ATP induced nuclear translocation.
These data suggest that both dye and Oct-STR endocytosis com-
plex could modulate nuclear internalization of Tat peptides.
 2007 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Numerous studies have shown that the Tat protein basic do-
main residues 48–57 (GRKKRRQRRR) from human immu-
nodeﬁciency virus (HIV-1) rapidly permeate plasma
membranes and translocate into the nucleus [1–5]. This mech-
anism is currently used to deliver proteins and nucleic acids to
cell nuclei through covalent linkages [2]. Similarly, conjugation
of molecular probes such as ﬂuorescein 5 0-carboxylic acid (5-
FAM) [4] and green ﬂuorescent protein (GFP) [3,5] with Tat
peptides provides an opportunity to image intracellular pro-
cesses by optical methods.
Recent advances in laser technology and image reconstruc-
tion algorithms have re-ignited interest in the use of optical
imaging as a powerful method to diagnose pathologic condi-
tions as well as complement existing imaging modalities [6–
10]. The use of exogenous optical molecular probes can en-
hance the rapid visualization of pathologic tissues. In previous
studies, we demonstrated that conjugating a somatostatin
receptor-avid peptide (octreotate, Oct) with ﬂuorescent dyesAbbreviations: STR2, somatostatin receptor subtype 2; Oct, octreotate;
BN, bombesin peptide analogue; 5-FAM, ﬂuorescein 5 0-carboxylic
acid; NLS, nuclear localization signal; LRP, lipoprotein receptor-
related protein; HSPGs, heparan sulfate proteoglycans
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doi:10.1016/j.febslet.2007.03.067improves the speciﬁcity of imaging cancers in rodents by con-
trast agent-mediated optical imaging [11]. Targeting somato-
statin receptor subtype 2 (STR2) is attractive because it is
up-regulated in cancer cells and several clinical studies have
successfully used STR-targeted radiopharmaceuticals to image
various forms of tumors and pathologic conditions [12,13]. To
increase the rate of tumor localization, we explored the eﬀects
of labeling a tandem Tat-Oct peptide conjugate with ﬂuores-
cent dyes, which are useful for cellular and whole-body optical
imaging studies. Unfortunately, Tat-peptides are known to
translocate into cell nuclei, rendering this approach less attrac-
tive for imaging agents because of potential undesirable muta-
genesis.
In this study, we prepared a pair of three groups of com-
pounds and assessed their cellular uptake and localization in
STR-positive and negative cell lines: (a) 5-FAM and Cy-
pate2-Tat peptides, (b) Oct-5-FAM and Oct-Cypate2, and (c)
Tat-Oct-5-FAM and Tat-Oct-Cypate2 conjugates. We also
prepared bombesin (BN) receptor-avid peptide [14] to assess
the eﬀects of other secondary peptides on modulating the
activity of Tat peptides. The results show that nearly all the
Tat peptide conjugates internalized and localized rapidly in
cellular nuclei but a careful choice of a dye and a secondary
peptide can modulate the nuclear internalization of Tat pep-
tides. Particularly, we found that Tat-Oct-Cypate2 promoted,
but Tat-Oct-5-FAM inhibited, the nuclear internalization of
the Tat peptide residue. Interestingly, addition of ATP to the
culture medium can reestablish the internalization of the prod-
uct in the cell nucleus. This ﬁnding is applicable to another
receptor-avid bombesin peptide when conjugated to Tat pep-
tide, suggesting the potential to use a variety of secondary pep-
tides to alter the intracellular distribution of Tat peptides.
Thus, the internalization of Tat peptides in the nucleus can
be modulated by a combination of Oct and 5-FAM and the
potential to reverse this process with ATP provides a strategy
to selectively destroy target tissues by mutagenesis.2. Materials and methods
2.1. Synthesis of probe Cypate2
A solution of triethyl orthoformate (0.6 g, 4.0 mmol) in acetoni-
trile (7.0 mL) was added dropwise into a stirred solution of 1,1,2-
trimethyl[1H]-benz[e]indole-3-propanoic acid (0.72 g, 2.0 mmol) in
pyridine (10.0 mL) under reﬂux for 2 h and concentrated. The resulting
residue was triturated with dilute HCl (5%), ﬁltered, washed
with water, and dried to aﬀord the desired product (0.61 g, 93%
yield). The observed molecular mass in electrospray ionization mass
spectrum (ESI-MS) corresponded to the calculated [MH]+ value of
573.41.blished by Elsevier B.V. All rights reserved.
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All amino acids were purchased from Novabiochem (San Diego,
CA, USA). The peptides were prepared on solid support by standard
ﬂuorenylmethyloxy (Fmoc) chemistry as described previously [15].
The tandem Tat-octreotate peptide was prepared by a one-pot syn-
thetic strategy on an automated peptide synthesizer (ACT 396). Start-
ing with threonine on Wang resin the tandem Tat-Oct peptide moieties
were prepared from the C-terminus of Oct to the N-terminus of Tat
48–57 (Fig. 1). The linker lysine between the OCT and Tat peptide se-
quences was protected with the orthogonal N-a-1-(4,4-dimethyl-2,6-
dixoxcyclohex-1-ylidene)ethyl-N-e-Fmoc group (Dde-Lys(Fmoc)-OH)
to allow the automated synthesis of the tandem peptide moieties using
Fmoc strategy. After peptide synthesis, the Dde group was removed
with 2% hydrazine in DMF before dye conjugation. The carboxyl
groups of Cypate2 or 5-FAM (Molecular Probes, Inc., Eugene, OR,
USA) were pre-activated with 2-(1H-benzotriazol-1-yl)-1,1,3,3-tetram-
ethyluronium hexaﬂuorophosphate (HBTU)/N-hydroxybenzotriazole
(HOBt) coupling reagent and coupled to the peptide on resin, as de-
scribed previously [14]. A similar approach was used to prepare the
analogous 5-FAM bombesin peptide analogues used in this study.
Cleavage of the peptide–dye conjugate from the solid support and con-
comitant removal of the side-chain protecting groups with TFA aﬀor-
ded the desired products, which were puriﬁed by HPLC and
characterized by ESI-MS and spectroscopic methods. Each of the
molecular probes was characterized by absorption and ﬂuorescence
spectroscopy in 20% aqueous DMSO.
1 Cypate2-K(RRRQRRKKRG-Ac)-OH (Tat-Cypate2), ESI-MS:
693.8 [M+3H+]3+.
2 5-FAM-K(RRRQRRKKRG-Ac)-OH (Tat-5-FAM), ESI-MS: 942
[M+H+]2+.
3 Cypate2-K(Ac)-f-cyclo(C-Y-w-K-T-C)-T-OH (Oct-Cypate2), ESI-
MS: 1604.5 [M+H+], 802.9 [M+H+]2+; f and w represent D-phenyl-
alanine and D-tyrosine, respectively.
4 5-FAM-K(Ac)-f-cyclo(C-Y-w-K-T-C)-T-OH (Oct-5-FAM), ESI-
MS: 1407 [M+H+].
5 Cypate2-K(RRRQRRKKRG-Ac)-f-cyclo(C-Y-w-K-T-C)-T-OH
(Tat-Oct-Cypate2), ESI-MS: 1577.3 [M+H+]2+; 1051.9 [M+3H+]3+.
6 5-FAM-K(RRRQRRKKRG-Ac)-f-cyclo(C-Y-w-K-T-C)-T-OH
(Tat-Oct-5-FAM), ESI-MS: 2957 [M+H+]; 1478.4 [M+2H+]2+,
992.1 [M+3H+]3+
7 5-FAM-K(RRRQRRKKRG-Ac)-GSGGQWVAGHLM-NH2
(Tat-BN-5-FAM), ESI-MS: 2957 [M+H+]; 1478.4 [M+2H+]2+;
992.1 [M+3H+]3+.
8 5-Fam-Gly-Ser-Gly-Gly-Gln-Trp-Val-Ala-Gly-His-Leu-Met-NH2
(BN-5-FAM), ESI-MS: 1499 [M+H+]; 749 [M+2H+]2+.
2.3. Cell culture and internalization studies
The STR-positive rat pancreatic carcinoma (AR42J) and the STR-
negative human lung cancer (A549) cell lines were purchased from
ATCC (Manassas, VA) and stored in 95% air/5% CO2 37 C. AR42JFig. 1. Structure of Tat-Oct-Cypate2. The ﬂuorescent dye was replaced with
peptide analogue (BN7-14) in Tat-BN-Cypate2. See text for details.cells were cultured in Ham’s F-12K medium supplemented with 20%
FBS, 1.5 mg/ml NaHCO3 and 2 mM L-glutamine. A549 cells were cul-
tured in Ham’s F-12K medium supplemented with 10% FBS, 1.5 mg/
ml NaHCO3 and 2 mM L-glutamine. Sub-culturing was performed in
a solution of 0.25% trypsin/0.1% EDTA. STR-negative human embry-
onic kidney 293A (HEK 293) cells (Invitrogen, Carlsbad, CA) were
cultured in DMEM medium supplemented with 10% fetal bovine ser-
um (FBS). The cells (1 · 105 cells/well) were grown on LabTek 8-cham-
ber slides (Nunc Inc. Rochester, NY) overnight prior to the
experiment. All compounds were dissolved in 20% aqueous DMSO
and diluted in 0.01 M PBS (pH 7.4) (Sigma, St. Louis, MO) to a con-
centration of 10 lM. Each compound (10 lM) was added to the cells
in chambers to obtain ﬁnal concentration of 1 lM and incubated at
37 C or 4 C. The samples were analyzed at diﬀerent time points.
For blocking studies, cells were pre-incubated in 1 lM of the corre-
sponding unlabeled peptides for 3–4 h at 37 C before adding 1 lM
of the molecular probes and incubated for another 15 h at 37 C. After
washing (4·) with 0.01 M PBS (pH 7.4), cells were ﬁxed with 4% para-
formaldehyde for 30 min and treated with 0.1% Triton-X for 2 min at
room temperature. This step was omitted for the live cell study. Subse-
quently, the cells were stained for 30 min with 1:2000 ToPro3 (Invitro-
gen) for ﬁxed cells at room temperature, and 2 h for live cells at 37 C.
Cells were mounted in 50% glycerol in 0.01 M PBS (pH 7.4), covered
with coverslips and sealed with nail polish. Olympus confocal laser
scanning microscope (FV1000) was used to analyze all samples.
2.4. Determination of molecular probe internalization by confocal
microscopy
The internalization of Cypate2 labeled compounds was monitored
by using 568 laser sources for excitation and monitored at 605–
620 nm. The 5-FAM labeled compounds were excited at 488 nm and
monitored at 510–550 nm. Internalization of the molecular probes in
cells was observed at 0.5 h, 1 h, 2 h, 4 h, and 15 h incubation in ﬁxed
and live AR42J cells. The cells incubated with culture medium or To-
pro3 (nuclear dye) alone in 0.01 M PBS buﬀer were used as control.
The imaging parameters were kept constant between control and sam-
ple groups. A 60· water-merged objective lens was used for micros-
copy. For optical sectioning by confocal microscopy, a few cells
were used to avoid color overlap of the diﬀerent cells in X–Y and X–
Z images. Z-axis dimension of each image was 5–6 lm and the X–Z
images are presented as short stacks of three optical sections recon-
structed with Olympus Fluoview software (v1.4a). Quantitation was
performed by counting the number of cells with nuclear internalization
of the molecular probes (Table 1) and measurement of ﬂuorescence
intensity in the nucleus and cytoplasm at diﬀerent time points. For
the kinetics experiment, three lines were drawn in the nucleus of diﬀer-
ent cells in each image and the mean ﬂuorescence intensity of the lines
was measured by the Fluoview software. The ﬂuorescence intensity
was normalized to control (5-FAM or Cypate2) at diﬀerent time
points.5-FAM in Tat-Oct-5-FAM and octreotate was replaced with bombesin
Table 1
The total cell number of the nuclear or/and cytoplasmic internalization
of 1 lM Tat or Oct peptides in AR42J cells
Compounds Total cell number (% cell number of nuclear
internalization)
0.5 h 1 h 2 h 4 h 15 h
Tat-Cypate2 96(100) 76(100) 126(100) 70(100) 140(100)
Oct-Cypate2 105(69) 80(89) 77(100) 100(92) 92(97)
T-O-Cypate2 82(100) 95(100) 81(100) 108(100) 169(100)
T-5-FAM 79(100) 83(100) 73(100) 87(100) 76(100)
O-5-FAM 87(3) 80(3) 81(3) 72(3) 104(2)
T-O-5-FAM 82(3) 108(2) 76(1) 74(2) 106(4)
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3.1. Peptide design and synthesis
Tat peptide-mediated cell permeation is a viable method for
intracellular delivery of drugs but the non-speciﬁc uptake and
translocation into cell nucleus may limit their use in molecular
imaging. To overcome these problems, we assessed the feasibil-
ity of controlling the nuclear internalization of Tat peptides
and their speciﬁc delivery to tumor cells by using a three-com-
ponent molecular design. The new molecule consists of the
decapeptide sequence of the HIV Tat protein for cell perme-
ation, a STR-avid octapeptide sequence for speciﬁc cell uptake
by STR-positive cells, and a ﬂuorescent carbocyanine (Cy-
pate2) or xanthene (5-FAM) dye to serve as the antenna for
optical imaging. Analogues of these dyes (indocyanine green
and ﬂuorescein disodium salt) have been used in human pa-
tients, providing a strategy to incorporate ﬁndings with these
molecular probes in human studies. A lysine residue was used
to link the Tat and Oct peptide residues to obtain Tat-Oct-5-
FAM and Tat-Oct-Cypate2. To evaluate the modulation of
nuclear internalization of Tat-Oct tandem peptide and delin-
eate the eﬀects of the individual peptide components, we also
prepared and labeled Tat peptide and Oct with 5-FAM and
Cypate2. These compounds were used to assess the eﬀects of
each component. Similarly, bombesin receptor-avid octapep-
tide was conjugated to 5-FAM-Tat peptide to further evaluate
the applicability of the nuclear internalization pattern to other
molecular constructs. A representative structure (Tat-Oct-Cy-
pate2) of the molecular probes is shown in Fig. 1. The absorp-
tion/emission maxima in 20% aqueous DMSO centered at 585/
606 nm for Cypate2 and 498/522 nm for 5-FAM. The spectral
proﬁles of the dyes were retained after conjugation to the pep-
tides on solid support.
3.2. Endocytosis of molecular probes was not a ﬁxation artifact
We studied the internalization proﬁles of the novel molecu-
lar probes in STR-positive tumor cells AR42J [16], STR-nega-
tive tumor cells A549 and STR-negative HEK 293 cells of non-
tumor origin. The AR42J was used to assess STR-mediated
internalization in tumor cells [17,18] and the A549 and HEK
293 cells served as negative controls for receptor-mediated
endocytosis.
Some studies have suggested that translocation of Tat pep-
tides across cell membrane occurred in ﬁxed cells but to a lesser
extent in live cells. These data were obtained by using either
4% formaldehyde or 100% methanol that induced a massive
nuclear redistribution [5,19]. Consequently, we ﬁxed the cells
with 4% paraformaldehyde to avoid the ﬁxation artifact and
compared the eﬀects of this ﬁxation solution on live and theﬁxed cells. After incubating with 1 lM Tat-5-FAM or Oct-5-
FAM, we observed that the internalization pattern in AR42J
cells were the same between live and ﬁxed cells. However, when
the cells were ﬁxed with 100% methanol, Oct-5-FAM internal-
ized in the nucleus (not shown), which is attributable to a ﬁx-
ation artifact. This result is similar to the observed nuclear
translocation of FITC conjugated PTD peptide after 100%
methanol ﬁxation [5]. For this reason, we ﬁxed cells with 4%
paraformaldehyde instead of 4% formaldehyde or 100% meth-
anol.3.3. 5-FAM and Oct cytoplasmic endocytosis complex modulate
nuclear internalization of Tat peptides
Three-dimensional confocal microscopy images show the
internalization of 5-FAM- and Cypate2-labeled Tat, Oct,
and Tat-Oct in AR42J cells. At 30 min post-incubation the
Tat-5-FAM distributed in both the nucleus and cytoplasm of
the cells, with predominant localization in the nucleus after
4 h (Fig. 2A–C). Expectedly, the STR-avid molecular probe,
Oct-5-FAM, was retained in the cytoplasm of AR42J cells at
all time points examined (Fig. 2G–I). As a G-protein-coupled
receptor, the Oct-5-FAM was likely endocytosized by STR
into the lysosomal compartment before re-distribution in the
cytosol or other cellular organelles [20]. Interestingly, Tat-
Oct-5-FAM was also internalized in AR42J cells (Fig. 2M–
O) but had intracellular distribution pattern similar to
Oct-5-FAM instead of Tat-5-FAM. By contrast, all of the
Cypate2-labeled peptides distributed in the cytoplasm and nu-
cleus, irrespective of the internalization mechanism (Fig. 2).
Compared with Tat-Cypate2 and Tat-Oct-Cypate2, the level
of Oct-Cypate2 in the nucleus is low. These results suggest that
the inﬂuence of Tat peptide moiety is not mitigated by either
Cypate2 or Oct-Cypate2 conjugate and reﬂect the contribution
of Oct-5-FAM endocytosis complex in modulating nuclear
internalization of Tat peptide.
Unlike receptor-mediated endocytosis, previous studies have
shown that intracellular retention of Tat-peptide conjugates is
not inhibited at low temperatures [5]. To evaluate how the cell
traﬃcking of Tat peptide will be aﬀected, we incubated AR42J
cells with six molecular probes at 4 C (Fig. 3). Consistent with
STR- and Tat peptide-mediated internalization mechanisms,
the uptake of OCT-5-FAM and Oct-Cypate2 was inhibited
at this low temperature while internalization of Tat-5-FAM
and Tat-Cypate2 was not aﬀected. By comparing the ﬂuores-
cence intensity in Fig. 2A and D with Fig. 3A and D, the
amount of these Tat peptide conjugates in the nucleus at
4 C decreased relative to incubation at 37 C. Evaluation of
the molecular probes possessing both Tat peptide and Oct in
the same molecule showed that uptake of Tat-Oct-5-FAM
but not Tat-Oct-Cypate2 was inhibited (Fig. 3C and F). How-
ever, comparison of Fig. 2P and Fig. 3F conducted at 37 C
and 4 C, respectively shows that the ﬂuorescence intensity
of 3F decreased by about 50%, indicating the contribution of
the Tat-peptide moiety to the observed cell uptake. These re-
sults demonstrate that the internalization of Tat peptide can
be modulated by a combination of a receptor-avid peptide
and a ﬂuorescent dye. In addition, the ability to inhibit the
internalization of the molecular probes in AR42J with equimo-
lar amounts of analogous non-labeled peptides suggests that
the endocytosis of each labeled and unlabeled compounds oc-
curred through a common pathway.
Fig. 2. Intracellular distribution of 1 lM 5-FAM and Cypate2 labeled Tat-(A–F), Oct-(G–L) and Tat-Oct-(M–R) compounds in AR42J cells at
37 C for 0.5 h, 1 h, and 4 h. Color scheme: nuclear stain, blue; 5-FAM, green; Cypate2, red; Green/blue overlap, light green; red/blue overlap,
purple.
Fig. 3. Incubation of AR42J cells with molecular probes at 4 C for
30 min: Tat-5-FAM (A), Oct-5-FAM (B) and Tat-Oct-5-FAM (C),
Tat-Cypate2 (D), Oct-Cypate2 (E) and Tat-Oct-Cypate2 (F). Except
for (C), incubation at 4 C did not abolished the nuclear translocation
of 1 lM Tat compounds. Color scheme: nuclear stain, blue; 5-FAM,
green; Cypate2, red; Green/blue overlap, light green; red/blue overlap,
purple.
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tumor cells
In the light of the results above indicating the internalization
of the peptide molecular probes in STR-positive AR42J cells,
we further assessed the uptake of the molecular probes in
STR-negative (A549) tumor and non-tumor (HEK) cell lines.
A similar internalization pattern was observed for the Tat-5-
FAM and Tat-Cypate2 in all cell lines, with the molecular
probes distributed between the cell nucleus and cytoplasm
(Fig. 4A–D). Expectedly, the STR-avid molecular probes,
Oct-Cypate2 and Oct-5-FAM, did not internalize in both
HEK and A549 cells (Fig. 4E–H) lines, indicating the role of
the receptor in mediating their intracellular traﬃcking inAR42J cells. However, we also noted that both Cypate2- and
5-FAM-labeled Tat-Oct peptides did not accumulate in the
STR-negative cell lines (Fig. 4I–L). While this ﬁnding may
be expected for Tat-Oct-5-FAM, the absence of internalization
of Tat-Oct-Cypate2 in these cells was surprising because of its
enhanced uptake in the AR42J cells. The ensemble of the re-
sults suggests that the initial binding of Oct to STR on cell
membrane facilitates intracellular transport by Tat peptide
even at low temperature for Tat-Oct-Cypate2 in AR42J cells
(Fig. 3F). Conversely, the absence or low expression of STR
in HEK and A459 cells may allow Oct moiety to interfere with
the internalization of Tat-Oct-Cypate2 at 30 min post-incuba-
tion. These ﬁndings could be useful in designing molecular
probes for assessing cell traﬃcking pathways.
3.5. Oct-Cypate2 promotes and Oct-5-FAM inhibits the nuclear
internalization of Tat peptide
Regardless of the incubation time, Table 1 shows that the
long-term distribution of the Tat peptides in AR42J cells is
predictable within 30 min post-incubation. Nearly all the cells
incubated with Cypate2-labeled compounds showed nuclear
internalization spanning from 0.5 h to 15 h. By comparison,
less than 5% of the cell population examined internalized the
5-FAM-labeled analogues in their nuclei, with the exception
of Tat-5-FAM which had similar distribution pattern as Cy-
pate2-labeled compounds. An interesting trend in the nuclear
internalization is shown in Fig. 5, where either 5-FAM or Cy-
pate2 was used as reference. When labeled with 5-FAM, the
ﬂuorescence intensity of the nuclear component peaked after
1 h incubation and progressively decreased with time, ﬂatten-
ing out at about 4 h post-incubation. At maximum intensity,
the ﬂuorescence of Tat-5-FAM was nearly 3· those of Oct-5-
FAM and Tat-Oct-5-FAM, which were close to background
ﬂuorescence. In contrast, the Tat-Oct-Cypate2 had similar
nuclear internalization dynamics as Tat-Cypate2 than Oct-Cy-
pate2 up to 4 h post-incubation. After 4 h, the nuclear intensity
of Tat-Oct-Cypate2 continued to increase but that of Tat-Cy-
Fig. 4. Intracellular distribution of molecular probes (1 lM) in HEK293 and A549 cells at 37 C for 30 min. Incubation of Tat-Cypate2, Oct-
Cypate2, and Tat-Oct-Cypate2 (A, E, I) or Tat-5-FAM, Oct-5-FAM, and Tat-Oct-5-FAM (B, F, J) with HEK cells and Tat-Cypate2, Oct-Cypate2,
and Tat-Oct-Cypate2 (C, G, K) or Tat-5-FAM, Oct-5-FAM, and Tat-Oct-5-FAM (D, H, L) with A549 cells. Color scheme: nuclear stain, blue; 5-
FAM, green; Cypate2, red; Green/blue overlap, light green; red/blue overlap, purple.
Fig. 5. The dynamics of nuclear internalization of 5-FAM-labeled (A)
and Cypate2-labeled (B) Tat-, Oct-, and Tat-Oct- compounds in
AR42J cells at 37 C. 5-FAM (A) or Cypate2 (B) was used as control
for the internalization study.
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pate2.
Although the exact rationale for this reversal is not obvious
at this time, it is likely that the internalization complex be-
tween STR and Tat-Oct-Cypate2 is resistant to the p-glycopro-
tein-mediated eﬄux of endocytosized compounds [21,22]. Such
disposition would favor retention of the molecular probes in
cells, thereby enhancing their uptake in the nucleus. It also al-
lows the cells to take advantage of receptor-recycling time to
increase the amount of internalized molecular probes at longer
incubation times. This ﬁnding provides a strategy to deliver
more materials to the nucleus and retain them for prolonged
period if needed. Considering that the diﬀerence between
Tat-Oct-Cypate2 and Tat-Oct-5-FAM resides in the ﬂuores-
cent dye used, this observation indicates the potential to con-
trol nuclear internalization of Tat peptide derivatives by a
combination of peptide modiﬁers and ﬂuorescent dyes.3.6. ATP facilitates nuclear internalization of all Tat peptide
derivatives
The mechanism of nuclear internalization of Tat peptide re-
mains poorly understood and controversial [3]. Recent studies
showed that Tat peptide promote endocytosis by binding to
negatively charged heparan sulfate proteoglycans (HSPGs)
on the cell surface [23,24]. Once internalized, the Tat peptide
sequence allowed active transport through the nuclear pore.
Notably, glypican-1, an abundant cell-surface HSPG, contains
nuclear localization signal (NLS) sequence and it is found in
the nuclear compartment of neurons and glioma cells [25].
Binding of HIV-1 Tat protein to low-density lipoprotein recep-
tor-related protein (LRP) promoted eﬃcient uptake of Tat
into neurons, and LRP-mediated uptake of Tat was followed
Fig. 6. ATP facilitated nuclear localization of 1 lM Oct-5-FAM (B, C), Tat-Oct-5-FAM (E, F), BN-5-FAM (H, I), and Tat-BN-5-FAM (K, L) in
AR42J cells at 37 C for 4 h and 15 h. Panels A, D, G, and J are non-ATP treated components. Color scheme: nuclear stain, blue; 5-FAM, green;
Green/blue overlap, light green.
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ceivable that LRP and HSPG cooperate during internalization
of Tat peptides, some of which may escape lysosomal degrada-
tion to exert biological activities in the nuclear compartment
[27]. Moreover, cytoplasmic and nuclear delivery of Tat-de-
rived peptides has been shown to be an ATP-dependent path-
way after endocytic uptake into HeLa cells [4].
In this study, the observed inability of Tat-Oct-5-FAM to
translocate into the nucleus of AR42J cells is in sharp contrast
to a previous report that Tat-p27-5-FITC protein localized in
cytoplasm and nucleus of cells [28]. It should be noted that
FITC and 5-FAM are ﬂuorescein derivatives. The Cdk inhibi-
tion protein, p27, has an NLS domain near its carboxy termi-
nus that can mediate nuclear translocation of the labeled
compound [28–31]. The lack of nuclear internalization by
Tat-Oct-5-FAM, coupled with competing binding of the
molecular construct to STR on the surface of AR42J cells,
could modulate the subcellular distribution. It is also known
that ﬂuorescein is a selective inhibitor of (Na–K)-ATPase
and this inhibition of ATPase activity can be reversed by
ATP [32]. Apparently, in the presence of the octreotate pep-
tide, 5-FAM, but not Cypate2 acted as an ATPase inhibitor.
Consequently, addition of 4 mM ATP to the culture medium
facilitated the translocation of Oct-5-FAM and Tat-Oct-5-
FAM to nucleus (Fig. 6A–F), resulting in a similar subcellular
distribution found in most Tat peptide-mediated intracellular
transport of materials. Thus, nuclear internalization of Tat-
Oct peptides can be enhanced by ATP, which is consistent with
the ﬁnding of Potocky et al. [4]. Apparently, in the presence of
Oct, 5-FAM, but not Cypate2 acted as an ATPase inhibitor.
Our data further suggest that neither Oct or 5-FAM alone is
suﬃcient to modulate the nuclear internalization of Tat-Oct-
5-FAM, establishing the importance of the endoplasmic com-
plex between STR and Oct-5-FAM in nuclear translocation.
To explore the applicability of this ﬁnding to other receptor-
mediated molecular constructs, we also prepared 5-FAM-
labeled bombesin peptide (BN) analogues similar to Oct
derivatives. BN and its truncated peptide analogue, BN7-14,bind gastrin releasing peptide receptor (GRPr) in epithelial
cells [33] and AR42J cells [9,34] by a similar mechanism to
STR. In sharp similarity to Oct-5-FAM and Tat-Oct-5-
FAM, we found that 4 mM ATP also facilitated the nuclear
uptake of BN-5-FAM and Tat-BN-5-FAM in AR42J cells
(Fig. 6G–L). Together, our data demonstrate that a synergistic
eﬀect of the complex between Oct and STR or BN and GRPr
with 5-FAM modulate the translocation of Tat-Oct-5-FAM to
the nucleus. More importantly, the results show that incorpo-
rating secondary peptides and ﬂuorescent dyes to Tat peptides
could provide an important strategy to increase, retain, or in-
hibit nuclear internalization of Tat peptides.
In conclusion, incorporating a dye and a secondary peptide
into Tat peptides can modulate its nuclear internalization over
a long period. Conjugation of a hydrophobic dye such as Cy-
pate2 to Tat peptide can enhance and retain nuclear internal-
ization. Together with a secondary peptide, a hydrophilic
dye such as 5-FAM inhibits nuclear internalization of Tat pep-
tides. Addition of ATP overcomes this inhibition and provides
a viable strategy to modulate the activities of Tat peptides for
in vitro and in vivo applications. It is hoped that the rapid
internalization of site-speciﬁc Tat peptides will enhance their
localization and retention in target tissues, increase clearance
from non-target tissues, and reduce the amount of the molec-
ular probe administered in patients.
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